Compare · GEV vs JMAC
GEV vs JMAC
Side-by-side comparison of GE Vernova Inc. (GEV) and Maxpro Capital Acquisition Corp. (JMAC): market cap, price performance, sector, and recent activity on the wire.
Summary
- GEV operates in Technology, while JMAC operates in Industrials - the two are in different parts of the market.
- GEV carries a market cap of $213.92B.
- GEV has hit the wire 7 times in the past 4 weeks while JMAC has been quiet.
- GEV has more recent analyst coverage (25 ratings vs 0 for JMAC).
- Company
- GE Vernova Inc.
- Maxpro Capital Acquisition Corp.
- Price
- $809.09+1.54%
- -
- Market cap
- $213.92B
- -
- 1M return
- -19.35%
- -
- 1Y return
- +40.53%
- -
- Industry
- Consumer Electronics/Appliances
- Consumer Electronics/Appliances
- Exchange
- NYSE
- NASDAQ
- IPO
- 2024
- 2021
- News (4w)
- 7
- 0
- Recent ratings
- 25
- 0
JMAC
Maxpro Capital Acquisition Corp.
Jade Mountain Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Taipei City, Taiwan.
Latest GEV
- GE Vernova Continues Wind Energy Expansion in Germany With New Order From Stadtwerke Heidenheim AG
- Amendment: SEC Form SCHEDULE 13G/A filed by GE Vernova Inc.
- GE Vernova upgraded by HSBC Securities with a new price target
- SEC Form 10-Q filed by GE Vernova Inc.
- SEC Form 8-K filed by GE Vernova Inc.
- GE Vernova to Acquire Trench Group
- Just 7% of the Uranium Delivered to U.S. Reactors Last Year Was U.S.-Origin. The Reactor Pipeline Is Still Moving.
- GE Vernova Declares Fourth Quarter 2026 Dividend
- US Utilities Plan 24 GW of New Battery Storage in 2026 as Interconnection Waits Stretch
- Studsvik, GE Vernova Hitachi and Samsung C&T commit to advancing 1.2 GW nuclear power project in Sweden
Latest JMAC
- SEC Form SC 13G/A filed by Maxpro Capital Acquisition Corp. (Amendment)
- SEC Form 15-12G filed by Maxpro Capital Acquisition Corp.
- SEC Form 10-K filed by Maxpro Capital Acquisition Corp.
- Apollomics, A Company Developing Novel Oncology Therapies To Address Difficult-To-Treat Cancers, Announces Closing Of Business Combination And Listing On Nasdaq
- Maxpro Capital Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Other Events, Financial Statements and Exhibits
- Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq
- Reported Late Wednesday March 29, Apollomics Announces Completion Of Business Combination With Maxpro Capital Acquisition Corp. And Listing On Nasdaq; Expected To Commence Trading On March 30, 2023, On The Nasdaq Capital Market Under The Symbols "APLM"
- SEC Form 4 filed by Chen Yi-Kuei (Alex)
- SEC Form 4 filed by Wu Soushan
- SEC Form 4 filed by Gau Wey - Chuan